IRIS
CANONICA, Giorgio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 18.874
AS - Asia 14.843
SA - Sud America 6.161
EU - Europa 4.553
AF - Africa 994
OC - Oceania 38
Continente sconosciuto - Info sul continente non disponibili 18
AN - Antartide 1
Totale 45.482
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 18.268
SG - Singapore 8.518
BR - Brasile 4.974
VN - Vietnam 2.397
CN - Cina 1.941
FI - Finlandia 975
IE - Irlanda 842
NG - Nigeria 601
DE - Germania 550
AR - Argentina 502
FR - Francia 469
GB - Regno Unito 378
NL - Olanda 310
CA - Canada 301
IN - India 282
IT - Italia 258
HK - Hong Kong 244
TR - Turchia 241
EC - Ecuador 225
BD - Bangladesh 224
ID - Indonesia 216
RU - Federazione Russa 206
MX - Messico 171
CO - Colombia 129
IQ - Iraq 129
ZA - Sudafrica 126
SE - Svezia 122
UA - Ucraina 95
IL - Israele 94
PY - Paraguay 93
PK - Pakistan 77
CL - Cile 70
VE - Venezuela 69
PL - Polonia 62
SA - Arabia Saudita 59
UZ - Uzbekistan 56
ES - Italia 51
EG - Egitto 47
MA - Marocco 46
KE - Kenya 44
UY - Uruguay 41
TN - Tunisia 40
JP - Giappone 38
PE - Perù 34
DZ - Algeria 31
AU - Australia 29
BE - Belgio 29
KR - Corea 27
NP - Nepal 27
PH - Filippine 25
AZ - Azerbaigian 24
DO - Repubblica Dominicana 23
JO - Giordania 23
RO - Romania 23
AE - Emirati Arabi Uniti 21
BO - Bolivia 21
CZ - Repubblica Ceca 21
IR - Iran 20
JM - Giamaica 20
KZ - Kazakistan 20
AT - Austria 19
ET - Etiopia 18
AL - Albania 17
TT - Trinidad e Tobago 16
OM - Oman 15
BG - Bulgaria 14
KG - Kirghizistan 14
MY - Malesia 14
PA - Panama 14
GR - Grecia 13
LT - Lituania 13
SN - Senegal 11
SY - Repubblica araba siriana 11
HN - Honduras 10
LB - Libano 10
PT - Portogallo 10
AM - Armenia 9
CR - Costa Rica 9
GE - Georgia 9
PS - Palestinian Territory 9
A2 - ???statistics.table.value.countryCode.A2??? 8
CH - Svizzera 8
KW - Kuwait 8
MN - Mongolia 8
NI - Nicaragua 8
PR - Porto Rico 8
RS - Serbia 8
SV - El Salvador 8
BA - Bosnia-Erzegovina 7
BH - Bahrain 7
MD - Moldavia 7
AO - Angola 6
DK - Danimarca 6
GT - Guatemala 6
HR - Croazia 6
LV - Lettonia 6
TW - Taiwan 6
BW - Botswana 5
CI - Costa d'Avorio 5
GA - Gabon 5
Totale 45.390
Salva come PNG Salva come JPEG
Città #
Wilmington 4.529
Singapore 3.376
San Mateo 1.695
The Dalles 1.555
Dallas 1.090
Ann Arbor 1.031
Shanghai 1.000
Helsinki 972
Ho Chi Minh City 891
Leawood 866
Dublin 837
Ashburn 831
Lawrence 772
Princeton 771
Benin City 594
Fairfield 577
Woodbridge 514
Hanoi 500
Chandler 488
São Paulo 414
San Jose 410
Paris 402
Beijing 293
Amsterdam 271
Hong Kong 226
New York 205
London 193
Toronto 172
Kocaeli 168
Orem 153
Rio de Janeiro 145
Falkenstein 141
Los Angeles 125
Santa Clara 112
Boardman 108
Haiphong 101
Norwalk 98
Brasília 88
Curitiba 88
Guayaquil 87
Da Nang 84
Belo Horizonte 83
Porto Alegre 75
Chennai 69
Campinas 66
Biên Hòa 65
Guarulhos 61
Manchester 57
Dhaka 56
Quito 55
Salvador 52
Tashkent 51
Warsaw 50
Johannesburg 47
Buenos Aires 45
Montreal 45
Phoenix 45
Hải Dương 44
Asunción 43
Monmouth Junction 43
Moscow 43
Jakarta 41
Frankfurt am Main 39
Ninh Bình 39
Seattle 39
Mumbai 38
Montevideo 37
Ribeirão Preto 37
Baghdad 36
Milan 36
Nairobi 35
Sorocaba 35
Buffalo 34
Fortaleza 34
Goiânia 34
Thái Bình 34
São Bernardo do Campo 33
Can Tho 32
Thái Nguyên 32
Mexico City 30
Bogotá 29
Houston 29
Manaus 29
Phủ Lý 29
Recife 29
Cape Town 28
Ha Long 28
Medellín 28
Santiago 28
Santo André 28
Brooklyn 27
Caxias do Sul 27
Des Moines 27
New Delhi 27
Juiz de Fora 26
Lấp Vò 25
Nova Iguaçu 25
Chicago 24
Lahore 24
Piracicaba 24
Totale 29.284
Salva come PNG Salva come JPEG
Nome #
100 years of immunotherapy: the Monaco charter. under the high patronage of His Serene Highness Prince Albert II of Monaco 737
Quality of life and polysensitization in young men with intermittent asthma 214
A critical appraisal on AIT in childhood asthma. 149
Very rapid improvement of extended nitric oxide parameters, associated with clinical and functional betterment, in patients with chronic rhinosinusitis with nasal polyps (CRSwNP) treated with Dupilumab 132
Effects on symptoms and quality of life of hypertonic saline nasal spray added to antihistamine in persistent allergic rhinitis--a randomized controlled study 130
Shadow cost of oral corticosteroids-related adverse events: A pharmacoeconomic evaluation applied to real-life data from the Severe Asthma Network in Italy (SANI) registry 126
Omalizumab for Idiopathic Nonhistaminergic Angioedema: Evidence for Efficacy in 2 Patients. 125
Comparison of intranasal azelastine to intranasal fluticasone propionate for symptom control in moderate-to-severe seasonal allergic rhinitis 125
An academic allergy unit during COVID-19 pandemic in Italy. 116
Allergic sensitization to common pets (cats/dogs) according to different possible modalities of exposure: an Italian Multicenter Study. 115
A Charter to Improve Patient Care in Severe Asthma 106
A 4-year trial of tiotropium in chronic obstructive pulmonary disease 103
Immunological mechanisms underlying chronic rhinosinusitis with nasal polyps 101
Pidotimod: The state of art 101
Comparison of the colony forming capacities of human T lymphocyte subpopulations 101
A multi-allergen ELISA screening method. Comparison with Pharmacia CAP system and Phazet skin prick test 101
30 Years Of Sublingual Immunotherapy 101
A new protocol for specific oral tolerance induction in children with IgE-mediated cow's milk allergy 100
Aligning the Good Practice MASK With the Objectives of the European Innovation Partnership on Active and Healthy Ageing 98
60Co therapy as an "allergic breakthrough" in a case of food allergy 98
The Severe Asthma Network in Italy: Findings and Perspectives 96
Treatable traits in chronic rhinosinusitis with nasal polyps 96
2019 ARIA Care pathways for allergen immunotherapy 95
Evolving phenotypes to endotypes: is precision medicine achievable in asthma? 94
A model of allergen-driven human airway contraction:beta2 pathway dysfunction without cytokine involvement 92
Pitfalls in respiratory allergy management: alexithymia and its impact on patient-reported outcomes 90
360 degree perspective on allergic rhinitis management in Italy: A survey of GPs, pharmacists and patients 89
Adherence to treatment in allergic rhinitis using mobile technology. The MASK Study 89
Pharmacokinetics and pharmacodynamics of monoclonal antibodies for asthma treatment 88
A multicentric study on sensitivity and specificity of a new in vitro test for measurement of IgE antibodies 87
A double-blind, placebo-controlled study on the diagnostic accuracy of an electrodermal test in allergic subjects 87
Strategies to reduce corticosteroid-related adverse events in asthma 86
A common language to assess allergic rhinitis control: results from a survey conducted during EAACI 2013 Congress 86
Diagnosis and management of moderate to severe adult atopic dermatitis: a Consensus by the Italian Society of Dermatology and Venereology (SIDeMaST), the Italian Association of Hospital Dermatologists (ADOI), the Italian Society of Allergy, Asthma and Clinical Immunology (SIAAIC), and the Italian Society of Allergological, Environmental and Occupational Dermatology (SIDAPA) 84
Pharmacoeconomic evaluation of oral corticosteroid adverse events in patients with severe asthma 84
Appropriateness in allergic respiratory diseases health care in Italy: definitions and organizational aspects 83
International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis 83
Microarray Immunodiagnostics for Aeroallergens 82
Predictors of response to omalizumab and relapse in chronic spontaneous urticaria: a study of 470 patients 82
A new tool to evaluate the impact of chronic urticaria on quality of life: chronic urticaria quality of life questionnaire (CU-QoL) 82
GA(2)LEN skin test study I: GA(2)LEN harmonization of skin prick testing: novel sensitization patterns for inhalant allergens in Europe 82
[GA(2)LEN (Global Allergy and Asthma European Network): European network of excellence for asthma and allergic diseases] 82
New drugs in early-stage clinical trials for allergic rhinitis 80
EAACI: A European Declaration on Immunotherapy. Designing the future of allergen specific immunotherapy 80
[Our experience in the treatment of bronchial asthma and asthmatic bronchitis with salbutamol] 80
Real-life studies of biologics used in asthma patients: key differences and similarities to trials 79
A survey of the burden of allergic rhinitis in Europe 79
Escaping the trap of allergic rhinitis. 78
World Allergy Organization-McMaster University Guidelines for Allergic Disease Prevention (GLAD-P): Prebiotics 78
Rhinasthma: a new specific QoL questionnaire for patients with rhinitis and asthma 78
[Anti-leukotriene agents: rationale for and prospects of use] 77
EAACI/GA2LEN/EDF guideline: management of urticaria 77
Pilot study of mobile phone technology in allergic rhinitis in European countries: The MASK-rhinitis study 77
Work productivity in rhinitis using cell phones: The MASK pilot study 77
Turkish Version of the Chronic Urticaria Quality of Life Questionnaire: Cultural Adaptation, Assessment of Reliability and Validity 76
EAACI guidelines on allergen immunotherapy: Executive statement 76
Evaluation of the nocebo effect during oral challenge in patients with adverse drug reactions 76
Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials 76
EAACI/GA(2)LEN/EDF/WAO guideline: management of urticaria 75
Efficacy and Safety of High ICS Dose Fixed-Combination ICS/LABA/LAMA pMDI Compared with ICS/LABA and ICS/LABA plus LAMA in Patients with Uncontrolled Asthma: The TRIGGER Study 75
Performance evaluation of ImmunoCAP® ISAC 112: a multi-site study 75
[ICAM-1 and allergic inflammation] 75
The burden of chronic spontaneous urticaria is substantial: Real-world evidence from ASSURE-CSU 75
Suppressor activity of T cells bearing Fc-receptors for IgG on lymphoid colony formation 74
EAACI/GA2LEN/EDF guideline: definition, classification and diagnosis of urticaria 74
[Immunotherapy in Latin America. From the past to the future] 74
Benefit of SLIT and SCIT for Allergic Rhinitis and Asthma 73
Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen) 73
Guidance to 2018 good practice: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma 72
The EAACI/GA(2) LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update 72
Assessing biomarkers in a real-world severe asthma study (ARIETTA) 72
A critical evaluation of Anti-IL-13 and Anti-IL-4 strategies in severe asthma 72
Choosing wisely in Allergology: a Slow Medicine approach to the discipline promoted by the Italian Society of Allergy, Asthma and Clinical Immunology (SIAAIC) 72
The EAACI/GA²LEN/EDF/WAO Guideline for the Definition, Classification, Diagnosis and Management of Urticaria. The 2017 Revision and Update 71
Serious Asthma Events with Budesonide plus Formoterol vs. Budesonide Alone 71
Quality of life and patients' satisfaction in chronic urticaria and respiratory allergy 71
Efficacy and safety of treatment with biologicals (benralizumab, dupilumab, mepolizumab, omalizumab and reslizumab) for severe eosinophilic asthma 71
Current insights in allergen immunotherapy. 70
International consensus on allergy immunotherapy 70
GA2LEN (Global Allergy and Asthma European Network) addresses the allergy and asthma 'epidemic' 70
Vitamin D levels and allergic diseases. An italian cross-sectional multicenter survey 70
GA(2)LEN skin test study II: clinical relevance of inhalant allergen sensitizations in Europe 70
Minimal important difference of the Chronic Urticaria Quality of Life Questionnaire (CU-Q2oL) 70
Inhibitory effect of an antibody against alpha 1-acid glycoprotein (alpha 1-AGP) on autologous mixed lymphocyte reaction and anti-T3 T-lymphocyte activation 69
Cross-cultural adaptation and validation of the RhinAsthma Patient Perspective (RAPP) in Spanish 69
Quality-of-life issues in survivors to anaphylactic reactions to drugs 69
Clinical outcomes related to molecular allergy diagnosis 68
A role for the intranasal formulation of azelastine hydrochloride/fluticasone propionate in the treatment of allergic rhinitis 68
IgE allergy diagnostics and other relevant tests in allergy, a World Allergy Organization position paper 68
Allergic Rhinitis and its Impact on Asthma (ARIA): achievements in 10 years and future needs 67
The adhesion molecules of allergic inflammation: recent insights into their functional roles 67
Sublingual immunotherapy: World Allergy Organization position paper 2013 update 67
Randomized double-blind controlled study with sublingual carbamylated allergoid immunotherapy in mild rhinitis due to mites 67
«ICAM-1/ CD54 expression on conjunctival epithelium during pollen season» 67
Circulating T cell subsets in euthyroid Graves' disease 67
World Allergy Organization-McMaster University Guidelines for Allergic Disease Prevention (GLAD-P): Probiotics 67
Fall episodes in elderly patients with asthma and COPD - A pilot study 67
La diagnostica delle malattie autoimmuni 67
Roflumilast in moderate-to-severe chronic obstructive pulmonary disease treated with longacting bronchodilators: two randomised clinical trials 67
Analysis of the drop-out rate in patients receiving mepolizumab for severe asthma in real life 67
Totale 9.097
Salva come PNG Salva come JPEG
Categoria #
all - tutte 342.760
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 342.760
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021966 0 0 0 0 0 0 0 0 0 0 14 952
2021/20223.070 117 7 50 781 15 17 130 610 304 295 680 64
2022/20234.261 1.617 85 825 139 101 86 19 93 282 774 218 22
2023/20243.395 168 387 769 31 32 141 119 116 50 34 638 910
2024/20255.980 79 34 38 53 56 786 211 381 704 1.955 748 935
2025/202620.768 2.647 1.455 2.593 5.006 661 506 3.665 1.334 1.353 1.101 447 0
Totale 46.424